These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 16780569

  • 1. Management of advanced chronic kidney disease in primary care - current data from Germany.
    Herget-Rosenthal S, Quellmann T, Linden C, Reinhardt W, Philipp T, Kribben A.
    Int J Clin Pract; 2006 Aug; 60(8):941-8. PubMed ID: 16780569
    [Abstract] [Full Text] [Related]

  • 2. How does late nephrological co-management impact chronic kidney disease? - an observational study.
    Herget-Rosenthal S, Quellmann T, Linden C, Hollenbeck M, Jankowski V, Kribben A.
    Int J Clin Pract; 2010 Dec; 64(13):1784-92. PubMed ID: 21070529
    [Abstract] [Full Text] [Related]

  • 3. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 4. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Mar; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Mar; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 7. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 8. Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale).
    Thilly N, Boini S, Kessler M, Briançon S, Frimat L.
    Nephrol Dial Transplant; 2009 Mar; 24(3):934-9. PubMed ID: 19001561
    [Abstract] [Full Text] [Related]

  • 9. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, Harty J.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 11. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.
    Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A.
    Am J Kidney Dis; 2007 Nov 20; 50(5):733-42. PubMed ID: 17954286
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets.
    Thanamayooran S, Rose C, Hirsch DJ.
    Nephrol Dial Transplant; 2005 Nov 20; 20(11):2385-93. PubMed ID: 16046506
    [Abstract] [Full Text] [Related]

  • 13. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D.
    Adv Chronic Kidney Dis; 2007 Jan 20; 14(1):105-12. PubMed ID: 17200050
    [Abstract] [Full Text] [Related]

  • 14. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA.
    Adv Perit Dial; 2009 Jan 20; 25():85-8. PubMed ID: 19886324
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic kidney disease in general practice: prevalence, diagnosis, and standards of care.
    Glynn LG, Anderson J, Reddan D, Murphy AW.
    Ir Med J; 2009 Oct 20; 102(9):285-8. PubMed ID: 19902646
    [Abstract] [Full Text] [Related]

  • 18. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 20; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 19. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.
    Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM.
    J Am Board Fam Med; 2008 Jun 20; 21(6):522-30. PubMed ID: 18988719
    [Abstract] [Full Text] [Related]

  • 20. Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.
    Thilly N, Boini S, Kessler M, Briançon S, Frimat L.
    J Eval Clin Pract; 2009 Feb 20; 15(1):121-8. PubMed ID: 19239592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.